RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease
- PMID: 1356945
RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease
Abstract
Behçet's disease is known to be associated with HLA-B51. To address the possibility that a non-human leukocyte antigen (HLA) gene closely linked to the HLA-B gene, such as tumor necrosis factor (TNF)-alpha, TNF-beta, or ECl (the locus that determines the susceptibility to alloreactive natural killer [NK] cells), is involved in the susceptibility to Behçet's disease, NcoI and EcoRI restriction fragment length polymorphisms in the TNF-beta gene and the susceptibility to lysis by alloreactive NK cells were investigated in Behçet's patients. In our NcoI restriction fragment length polymorphism (RFLP) analysis in the TNF-beta gene, the frequency of the NcoI 5.5 kb homozygote was decreased considerably in the patients, especially those with the ocular lesions, in relation to the healthy controls. However, no significant difference was observed between these groups in the EcoRI RFLP band distribution in this gene or the in susceptibility to lysis by alloreactive NK cells. These results indicated that a non-HLA gene located around the TNF gene region centromic of the HLA-B gene was a candidate to control the genetic susceptibility to Behçet's disease.
Similar articles
-
TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.Br J Dermatol. 2006 Aug;155(2):350-6. doi: 10.1111/j.1365-2133.2006.07348.x. Br J Dermatol. 2006. PMID: 16882174
-
Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.Hum Immunol. 2007 Mar;68(3):201-5. doi: 10.1016/j.humimm.2006.12.006. Epub 2007 Jan 5. Hum Immunol. 2007. PMID: 17349875
-
Immunogenetic studies of Behçet's disease.Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):520-7. Rev Rhum Engl Ed. 1996. PMID: 8896070 Review.
-
Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3332-40. Invest Ophthalmol Vis Sci. 1992. PMID: 1358857
-
Pathogenic gene responsible for the predisposition of Behçet's disease.Int Rev Immunol. 1997;14(1):33-48. doi: 10.3109/08830189709116843. Int Rev Immunol. 1997. PMID: 9203025 Review.
Cited by
-
Inflammation-related cytokine gene polymorphisms in Behçet's disease.J Inflamm Res. 2015 Sep 28;8:173-80. doi: 10.2147/JIR.S89283. eCollection 2015. J Inflamm Res. 2015. PMID: 26451120 Free PMC article.
-
Behçet's disease: from Hippocrates to the third millennium.Br J Ophthalmol. 2003 Sep;87(9):1175-83. doi: 10.1136/bjo.87.9.1175. Br J Ophthalmol. 2003. PMID: 12928293 Free PMC article. Review.
-
The association of Behçet's syndrome with HLA-B51 as understood in 2021.Curr Opin Rheumatol. 2022 Jan 1;34(1):4-9. doi: 10.1097/BOR.0000000000000846. Curr Opin Rheumatol. 2022. PMID: 34690278 Free PMC article. Review.
-
Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.Clin Exp Immunol. 2000 Apr;120(1):162-6. doi: 10.1046/j.1365-2249.2000.01176.x. Clin Exp Immunol. 2000. PMID: 10759778 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials